Patent · US Active

Compounds for use in the treatment of kinetoplastid infection

US10815222B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

C.N.C.C.S. S.C.A.R.L. COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING · IT

Inventors

Ilaria Biancofiore · Pomezia, IT
Alina CIAMMAICHELLA · Pomezia, IT
Federica Ferrigno · Pomezia, IT
Steven Harper · Roma, IT
Savina Malancona · Pomezia, IT
Jesus Maria Ontoria Ontoria · Pomezia, IT
Giacomo Paonessa · Roma, IT
Simona Ponzi · Pomezia, IT
Vincenzo Summa · Pomezia, IT

Key dates

Filing date	Dec 21, 2017
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Dec 21, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a class of novel heterocyclic compounds, to pharmaceutical compositions containing the compounds and their use in the treatment of kinetoplastid infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.